Cathepsin cysteine protease inhibitors

Details for Australian Patent Application No. 2003219953 (hide)

Owner Axys Pharmaceuticals, Inc. Merck Frosst Canada Ltd.

Inventors Janc, James, W.; Lau, Cheuk; Black, Cameron; Li, Chun Sing; Bayly, Christopher, I.; Therien, Michel; McKay, Dan; Hirschbein, Bernard, L.; Mellon, Christophe; Green, Michael, J.; Palmer, James, T.; Gauthier, Jacques Yves; Leger, Serge; Baskaran, Chitra; Truong, Vouy-Linh

Agent Spruson & Ferguson

Pub. Number AU-B-2003219953

PCT Number PCT/US03/06147

PCT Pub. Number WO2003/075836

Priority 60/408,704 06.09.02 US; 60/361,818 05.03.02 US

Filing date 28 February 2003

Wipo publication date 22 September 2003

Acceptance publication date 1 November 2007

International Classifications

C07D 295/12 (2006.01) Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

A61K 31/275 (2006.01) - Nitriles

A61K 31/381 (2006.01) - having five-membered rings

A61K 31/404 (2006.01)

A61K 31/417 (2006.01)

A61K 31/42 (2006.01) - Oxazoles

A61K 31/4245 (2006.01) - Oxadiazoles

A61K 31/426 (2006.01) - 1,3-Thiazoles

A61K 31/427 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/44 (2006.01) - Non-condensed pyridines

A61K 31/4406 (2006.01) - only substituted in position 3, e.g. zimeldine

A61K 31/4409 (2006.01) - only substituted in position 4, e.g. isoniazid, iproniazid

A61K 31/4465 (2006.01) - only substituted in position 4

A61K 31/47 (2006.01) - Quinolines

A61K 31/495 (2006.01) - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

A61K 31/505 (2006.01) - Pyrimidines

A61K 31/5375 (2006.01) - 1,4-Oxazines, e.g. morpholine

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 1/02 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 3/14 (2006.01) Drugs for disorders of the metabolism

A61P 19/02 (2006.01) Drugs for skeletal disorders

A61P 19/08 (2006.01) Drugs for skeletal disorders

A61P 19/10 (2006.01) Drugs for skeletal disorders

Event Publications

31 July 2003 Complete Application Filed

  Priority application(s): 60/408,704 06.09.02 US; 60/361,818 05.03.02 US

30 October 2003 Application Open to Public Inspection

  Published as AU-B-2003219953

16 March 2006 Assignment before Grant

  Axys Pharmaceuticals, Inc.; Merck Frosst Canada & Co. The application has been assigned to Axys Pharmaceuticals, Inc.; Merck Frosst Canada Ltd.

1 November 2007 Application Accepted

  Published as AU-B-2003219953

28 February 2008 Standard Patent Sealed

25 September 2008 Corrigenda

  Applications Accepted - Name Index Under the Name Axys Pharmaceuticals, Inc., Application No. 2003219953, under INID (72), correct the name of the co-inventors to Truong, Vouy-Linh and Baskaran, Chitra

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003219954-Antagonistic anti-hFas ligand human antibodies and fragments thereof

2003219952-Granulator